BSI
NVO

Bennett Selby Investments’s Novo Nordisk NVO Stock Holding History

Bennett Selby Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Sell
34,997
-729
-2% -$31.3K 0.54% 30
2026
Q1 		$1.31M Sell
35,726
-22,701
-39% -$1.08M 0.46% 33
2025
Q4 		$2.97M Buy
58,427
+2,731
+5% +$140K 0.96% 20
2025
Q3 		$3.09M Buy
55,696
+4,465
+9% +$261K 1.02% 21
2025
Q2 		$3.54M Buy
51,231
+6,355
+14% +$432K 1.26% 18
2025
Q1 		$3.12M Buy
44,876
+16,651
+59% +$1.38M 1.23% 19
2024
Q4 		$2.43M Buy
28,225
+2,074
+8% +$224K 0.96% 21
2024
Q3 		$3.11M Buy
26,151
+2,614
+11% +$349K 1.31% 16
2024
Q2 		$3.36M Buy
23,537
+1,054
+5% +$140K 1.51% 15
2024
Q1 		$2.89M Buy
22,483
+468
+2% +$55.7K 1.35% 17
2023
Q4 		$2.28M Buy
22,015
+1,676
+8% +$166K 1.17% 18
2023
Q3 		$1.85M Buy
20,339
+653
+3% +$57.5K 1.08% 20
2023
Q2 		$1.59M Buy
19,686
+2,140
+12% +$175K 0.92% 22
2023
Q1 		$1.4M Buy
17,546
+4,574
+35% +$324K 0.91% 22
2022
Q4 		$878K Buy
12,972
+188
+1% +$11K 0.66% 29
2022
Q3 		$637K Buy
12,784
+4,580
+56% +$245K 0.51% 31
2022
Q2 		$457K Sell
8,204
-256
-3% -$14.2K 0.35% 39
2022
Q1 		$470K Buy
8,460
+698
+9% +$35.8K 0.28% 45
2021
Q4 		$435K Sell
7,762
-208
-3% -$11.3K 0.25% 44
2021
Q3 		$383K Buy
+7,970
New +$385K 0.25% 47

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Bennett Selby Investments's NVO Position: Q2 2026 in Review

Bennett Selby Investments reduced its Novo Nordisk (NVO) stake by 2% in Q2 2026, selling an estimated $31.3K and leaving 34,997 shares worth $1.68M. The position accounts for 0.54% of the portfolio, ranked #30.

Bennett Selby Investments first reported a position in NVO in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.54M in Q2 2025. 654 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bennett Selby Investments held 34,997 shares of Novo Nordisk worth $1.68M as of Q2 2026.
  • Bennett Selby Investments sold 729 Novo Nordisk shares in Q2 2026, an estimated $31.3K.
  • Novo Nordisk made up 0.54% of Bennett Selby Investments's portfolio in Q2 2026, its #30 holding.
  • Bennett Selby Investments first reported a position in Novo Nordisk in Q3 2021 and has held it in 20 quarters since.
  • Bennett Selby Investments's Novo Nordisk position peaked at $3.54M in Q2 2025.
  • 654 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bennett Selby Investments's 13F filing for Q2 2026, filed 24 Jul 2026.